Ra Medical Systems announced that there is an increase in clinical adoption by hospitals for its VIVO system. The three-dimensional non-invasive mapping system is one of the product lines within the company’s electrophysiology division, Catheter Precision, LLC. As previously announced, Catheter Precision recently expanded its sales and clinical support team in the United States as part of its full product launch in Q2 2023. Included in the evaluations over the next few weeks are a number of hospitals including Staten Island University Hospital, Wellspan Hospital in York, PA, Our Lady of the Lake Hospital in Baton Rouge, LA, Valley Hospital in Ridgewood, NJ, and Cleveland Clinic Akron, as well as Cleveland Clinic, main campus in Cleveland, Ohio.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RMED:
- Ra Medical Systems says LockeT device utilized in structural heart procedures
- Ra Medical Systems’ electrophysiology division expands international distributon
- Ra Medical’s Catheter Precision submits data for CE Mark on LockeT product
- Ra Medical announces first hospital to complete 100 procedures with VIVO system